Pharmaceutical compositions for the treatment of transplant rejection or autoimmune or inflammatory conditions comprising cyclosporin A and 40-0-(2-hydroxyethyl)-rapamycin

CAFC
  • US 6,239,124 B1
  • Filed: 01/28/1999
  • Issued: 05/29/2001
  • Est. Priority Date: 07/30/1996
  • Status: Expired due to Term
First Claim
Patent Images

1. A pharmaceutical composition comprising (I) cyclosporin A and (II) 40-O-(2-hydroxyethyl)-rapamycin, wherein the weight ratio I:

  • II is 2;

    1 to 180;

    1, in combination or association with a pharmaceutically acceptable diluent of carrier.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×